Pfizer
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Beyond's analysis on Pfizer
- — Pfizer shows early signs of a turnaround but faces a looming patent cliff that could erase gains
- — Pfizer's unusually high dividend yield signals strong income appeal, with management confident in its sustainability
- — Hedge funds highlight Pfizer as a top dividend pick after its Ibrance breast-cancer drug clears an FDA milestone, underscoring confidence in the drugmaker’s cash‑flow stability
- — Pfizer may soon achieve high‑single‑digit earnings growth, CEO signals
- — Evaluating investment potential: Lexicon vs. Pfizer
Recent news mentioning Pfizer
- — Should Dividend Investors Buy Pfizer Stock for Its High Yield or Invest in Eli Lilly for Its Dividend Growth?
- — Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline
- — AbbVie vs. Pfizer: Which Dividend Stock Is the Better Buy in September?
- — What Would It Take For Pfizer To Cut Its Dividend?
- — Pfizer Says Its Biggest Headwinds Are Finally Easing. Does That Change the Story for This Ultra-High-Yield Dividend Stock?
- — Pfizer’s Dividend Yield Is Enormous. But Is the Payout Still Growing?
- — Pfizer's Dividend Faces Big Questions. Here Are 3 Reasons It Should Survive.
- — Pfizer Raises 2026 Revenue Guidance to $62 Billion. Here’s What’s Behind the Beat
- — Is Pfizer's New Business Big Enough To Carry The Old One?
- — Pfizer (PFE), Valneva (VALN) Lyme Vaccine Moves to EMA Review Despite Phase 3 Caveat
- — Why Is Pfizer Stock Paying You So Much To Wait?
- — Pfizer Says Major Headwinds Are Easing as Pipeline, Obesity Plans Take Center Stage